共 50 条
- [31] DESIGN OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SNF472 FOR THE TREATMENT OF CALCIFIC UREMIC ARTERIOLOPATHY (CALCIPHYLAXIS)NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34Sinha, SmeetaChertow, GlennBrandenburg, VincentGould, LisaMiller, StephanSalcedo, CarolinaGarg, RekhaGold, AlexPerello, Joan
- [32] PULSAR: phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-on) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH)EUROPEAN RESPIRATORY JOURNAL, 2019, 54Badesch, DavidGibbs, SimonGomberg-Maitland, MardiHumbert, MarcMclaughlin, ValleriePreston, IoanaSouza, RogerioWaxman, AaronPena, Janethe De OliveiraBarnes, JenniferZhang, XioashaZeldin, Robert K.
- [33] A single-center, double-blind, randomized, placebo-controlled study of the safety and efficacy of botulinum toxin type A treatment of upper facial rhytides, in female subjectsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB228 - AB228Carruthers, JCarruthers, ADessain, A
- [34] Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled studyINTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2004, 133 (04) : 371 - 379Ratner, PHampel, FVan Bavel, JHowland, W
- [35] A double-blind, randomized, vehicle-controlled, parallel group, multicenter study to assess the efficacy and safety of a topical gel product containing ketoconazole USP 2% in the treatment of seborrheic dermatitisJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P122 - P122Beger, BHighton, ABarranco, CLegendre, R
- [36] A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Assess the Efficacy and Safety of Clindamycin 1.2% and Tretinoin 0.025% Combination Gel for the Treatment of Acne Rosacea Over 12 WeeksJOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (03) : 333 - 339Chang, Anne Lynn S.Alora-Palli, MariaLima, Xinaida T.Chang, Tiffany C.Cheng, CarolChung, Connie M.Amir, OmarKimball, Alexa B.
- [37] A multicenter, double-blind, randomized, placebo-controlled, parallel study of the safety and efficacy of BOTOX (botulinum toxin type A) purified neurotoxin in the treatment of focal upper limb spasticity poststrokeNEUROLOGY, 2001, 56 (08) : A78 - A78Brashear, AGordon, MFElovic, EKassicieh, DMarciniak, CTurkel, CDo, MJenkins, SW
- [38] A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1) (vol 41, pg 3387, 2023)VACCINE, 2025, 48Martinon-Torres, FedericoWysocki, JacekSzenborn, LeszekCarmona-Martinez, AlfonsoPoder, AiriDagan, RonRichmond, PeterGilbert, ChristopherTrudel, Marie-ChantaleFlores, SherylLupinacci, RobertMcfetridge, RichardWiedmann, Richard T.Chen, QiuxuGerrits, HanBanniettis, NatalieMusey, LuwyBickham, KaraKaminski, Janusz
- [39] A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopeciaJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (05) : 794 - 800Blume-Peytavi, UlrikeLoennfors, SannaHillmann, KathrinBartels, Natalie Garcia
- [40] Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial (vol 76, pg 418, 2017)JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1226 - 1226Reich, K.Armstrong, A. W.Foley, P.Song, M.Wasfi, Y.Randazzo, B.Li, S.Shen, Y-KGordon, K. B.